"Designing Growth Strategies is in our DNA"

Diabetes Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP-4 Inhibitors, SGLT2 Inhibitors, and Others), By Diabetes Type (Type 1, and Type 2), By Route of Administration (Oral, Subcutaneous, and Intravenous), By Distribution Channel (Online pharmacies, Hospital Pharmacies, and Retail Pharmacies), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI100570

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Diabetes, by Type, for Key Countries / Region, 2022
    2. Cost Burden, Diabetes, Key Countries, 2022
    3. Pipeline Analysis, by Key Players
    4. New Product Launches, by Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
    6. Impact of COVID-19 on Global Diabetes Drug Market
  5. Global Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Diabetes Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Insulin
      2. DPP-4 Inhibitors
      3. GLP-1 Receptor Agonists
      4. SGLT2 Inhibitors
      5. Others
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Type-1
      2. Type-2
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Subcutaneous
      3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa 
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Novo Nordisk A/S
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. Eli Lily & Company
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Novartis AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services Inc.)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Bayer AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Other Players
Read Less

Figure 1: Global Diabetes Drugs Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2: Global Diabetes Drugs Market Value Share (%), by Drug Class, 2022 & 2030

Figure 3: Global Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022 & 2030

Figure 4: Global Diabetes Drugs Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 5: Global Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 6: Global Diabetes Drugs Market Value (USD billion), by Region, 2022 & 2030

Figure 7: North America Diabetes Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 8: North America Diabetes Drugs Market Value Share (%), by Drug Class, 2022

Figure 9: North America Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 10: North America Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022

Figure 11: North America Diabetes Drugs Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 12: North America Diabetes Drugs Market Value Share (%), by Route of Administration, 2022

Figure 13: North America Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 14: North America Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022

Figure 15: North America Diabetes Drugs Market Value (USD billion), By Country, 2022 & 2030

Figure 16: North America Diabetes Drugs Market Value Share (%), By Country, 2022

Figure 17: Europe Diabetes Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 18: Europe Diabetes Drugs Market Value Share (%), by Drug Class, 2022

Figure 19: Europe Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 20: Europe Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022

Figure 21: Europe Diabetes Drugs Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 22: Europe Diabetes Drugs Market Value Share (%), by Route of Administration, 2022

Figure 23: Europe Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 24: Europe Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022

Figure 25: Europe Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 26: Europe Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 27: Asia Pacific Diabetes Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 28: Asia Pacific Diabetes Drugs Market Value Share (%), by Drug Class, 2022

Figure 29: Asia Pacific Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 30: Asia Pacific Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022

Figure 31: Asia Pacific Diabetes Drugs Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 32: Asia Pacific Diabetes Drugs Market Value Share (%), by Route of Administration, 2022

Figure 33: Asia Pacific Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 34: Asia Pacific Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022

Figure 35: Asia Pacific Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 36: Asia Pacific Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 37: Latin America Diabetes Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 38: Latin America Diabetes Drugs Market Value Share (%), by Drug Class, 2022

Figure 39: Latin America Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 40: Latin America Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022

Figure 41: Latin America Diabetes Drugs Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 42: Latin America Diabetes Drugs Market Value Share (%), by Route of Administration, 2022

Figure 43: Latin America Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 44: Latin America Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022

Figure 45: Latin America Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 46: Latin America Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 47: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 48: Middle East & Africa Diabetes Drugs Market Value Share (%), by Drug Class, 2022

Figure 49: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 50: Middle East & Africa Diabetes Drugs Market Value Share (%), by Diabetes Type, 2022

Figure 51: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 52: Middle East & Africa Diabetes Drugs Market Value Share (%), by Route of Administration, 2022

Figure 53: Middle East & Africa Diabetes Drugs Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 54: Middle East & Africa Diabetes Drugs Market Value Share (%), by Distribution Channel, 2022

Figure 55: Middle East & Africa Diabetes Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 56: Middle East & Africa Diabetes Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 57: Global Diabetes Drugs Market Share (%), By Company, 2022

Table 1: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019–2030

Table 2: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019–2030

Table 3: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2030

Table 4: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

Table 5: Global Diabetes Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 6: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 7: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 8: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 9: North America Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 10: North America Diabetes Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 11: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 12: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 13: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 14: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 15: Europe Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 16: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 17: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 18: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 19: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 20: Asia Pacific Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 21: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 22: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 23: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 24: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 25: Latin America Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 26: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 27: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 28: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 29: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 30: Middle East & Africa Diabetes Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Booklet
  • Oct, 2023
  • 2022
  • 2019-2021
  • 126

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X